ARCHIVES

Neutron Therapy Contracts Wind Down Next Year; DCT To Consider Whether To Continue Support

This article is from The Cancer Letter archive.

Vol. 14 No. 13 | March 25, 1988

Download PDF Visit The Full Archive

Related Articles

FDA Issues Final Rules On Patient Access To Investigational Drugs

September 11, 2009

Revlimid Also Demonstrates Response in Mantle Cell

July 29, 2011

At Least 25 CCOP Applicants Score High Enough To Virtually Assure Funding; Geography An Issue

May 13, 1983

AACR, NCCR Advocate Five-Year Plan to Reach $10 billion Annual Cancer Budget

April 30, 1999

Overdiagnosis Since Advent Of Prostate Cancer Screening

September 25, 2009

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

May 30, 2014